UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

A Single-Tube Multiplexed Assay for Detecting ALK , ROS1, and RET Fusions in Lung Cancer

The Journal of molecular diagnostics : JMD, 2014-03, Vol.16 (2), p.229-243

2014

Volltextzugriff (PDF)

Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4‐driven transcriptional state

Molecular oncology, 2022-03, Vol.16 (6), p.1309-1328

2022

Volltextzugriff (PDF)

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.710-719

2012

Volltextzugriff (PDF)

Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial Cells

Circulation research, 1999-10, Vol.85 (8), p.699-706

1999

Volltextzugriff (PDF)

Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways

European journal of pharmacology, 2004-04, Vol.489 (3), p.139-149

2004

Volltextzugriff (PDF)

PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor

Clinical cancer research, 2015-03, Vol.21 (6), p.1487-1496

2015

Volltextzugriff (PDF)

N-[3-(R)-tetrahydrofuranyl]-6-aminopurine riboside, an A1 adenosine receptor agonist, antagonizes catecholamine-induced lipolysis without cardiovascular effects in awake rats

The Journal of pharmacology and experimental therapeutics, 2003-04, Vol.305 (1), p.225

2003

Volltextzugriff (PDF)

Tonic activity of the rat adipocyte A1‐adenosine receptor

British journal of pharmacology, 2002-03, Vol.135 (6), p.1457-1466

2002

Volltextzugriff (PDF)

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Journal of thoracic oncology, 2014-03, Vol.9 (3), p.285-294

2014

Volltextzugriff (PDF)

Abstract LB-215: Analysis of mutations associated with response to glasdegib in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-215-LB-215

2018

Volltextzugriff (PDF)

Inverse Agonists and Neutral Antagonists of Recombinant Human A1 Adenosine Receptors Stably Expressed in Chinese Hamster Ovary Cells

Molecular pharmacology, 1998-05, Vol.53 (5), p.886-893

1998

Volltextzugriff (PDF)

Abstract 940: Identification of Palbociclib response signature across indications

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.940-940

2015

Volltextzugriff (PDF)

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer

International journal of cancer, 2016-01, Vol.138 (1), p.195-205

2016

Volltextzugriff (PDF)

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Clinical cancer research, 2012-09, Vol.18 (18), p.5008-5019

2012

Volltextzugriff (PDF)

Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer

Future oncology (London, England), 2020-01, Vol.16 (1), p.4289-4301

2020

Volltextzugriff (PDF)

Abstract A1-52: Identification of drug-sensitive Notch receptor alterations in human breast cancer

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_1), p.A1-A1-52

2015

Volltextzugriff (PDF)

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)

Molecular cancer therapeutics, 2013-12, Vol.12 (12), p.2929-2939

2013

Volltextzugriff (PDF)

Abstract 1958: Interrogating hedgehog pathway and smoothened inhibition by PF-04449913 in patient-derived acute myeloid leukemia models

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1958-1958

2014

Volltextzugriff (PDF)

Abstract A2-33: Molecular profiling of patient-derived xenograft models across cancers

Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22_Supplement_1), p.A2-A2-33

2015

Volltextzugriff (PDF)

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer: NOTCH1 Gene Copy Number Gain

International journal of cancer, 2016-01, Vol.138 (1), p.195-205

2016

Volltextzugriff (PDF)

Abstract 3493: A single-tube, multiplexed, transcript-based assay to detect ALK, ROS1 and RET fusions in lung cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3493-3493

2013

Volltextzugriff (PDF)

Tonic activity of the rat adipocyte A 1 ‐adenosine receptor

British journal of pharmacology, 2009-02, Vol.135 (6), p.1457-1466

2009

Volltextzugriff (PDF)

Abstract LB-302: Activity of PF-04691502, A dual PI3K/mTOR inhibitor in breast cancer cell lines and models discriminates between ER, PR and HER2 positive and negative segments

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-302-LB-302

2010

Volltextzugriff (PDF)

LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart

The Journal of pharmacology and experimental therapeutics, 1997-08, Vol.282 (2), p.554

1997

Volltextzugriff (PDF)

Abstract LB-220: Molecular predictors of sensitivity to an IGF1R inhibitor in pre-clinical models of lung and colon cancers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-220-LB-220

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(14)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Animals
(11)
Oncology
(8)
Female
(6)
Male
(6)
Biological And Medical Sciences
(5)
Mice
(5)
Cell Line, Tumor
(4)
Lung Neoplasms - Genetics
(4)
Medical Sciences
(4)
Xenograft Model Antitumor Assays
(4)
Adenosine - Pharmacology
(3)
Antineoplastic Agents - Pharmacology
(3)
Cyclic Amp - Metabolism
(3)
Gene Expression Profiling
(3)
Lung Neoplasms - Drug Therapy
(3)
Mutation
(3)
Pharmacology. Drug Treatments
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Single-Tube Multiplexed Assay for Detecting ALK , ROS1, and RET Fusions in Lung Cancer

Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4‐driven transcriptional state

An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735

Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial Cells

Receptors for bitter, sweet and umami taste couple to inhibitory G protein signaling pathways

PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor

N-[3-(R)-tetrahydrofuranyl]-6-aminopurine riboside, an A1 adenosine receptor agonist, antagonizes catecholamine-induced lipolysis without cardiovascular effects in awake rats

Tonic activity of the rat adipocyte A1‐adenosine receptor

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Abstract LB-215: Analysis of mutations associated with response to glasdegib in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Inverse Agonists and Neutral Antagonists of Recombinant Human A1 Adenosine Receptors Stably Expressed in Chinese Hamster Ovary Cells

Abstract 940: Identification of Palbociclib response signature across indications

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer

Abstract A1-52: Identification of drug-sensitive Notch receptor alterations in human breast cancer

Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)

Abstract 1958: Interrogating hedgehog pathway and smoothened inhibition by PF-04449913 in patient-derived acute myeloid leukemia models

Abstract A2-33: Molecular profiling of patient-derived xenograft models across cancers

A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer: NOTCH1 Gene Copy Number Gain

Abstract 3493: A single-tube, multiplexed, transcript-based assay to detect ALK, ROS1 and RET fusions in lung cancer

Tonic activity of the rat adipocyte A 1 ‐adenosine receptor

Abstract LB-302: Activity of PF-04691502, A dual PI3K/mTOR inhibitor in breast cancer cell lines and models discriminates between ER, PR and HER2 positive and negative segments

LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart

Abstract LB-220: Molecular predictors of sensitivity to an IGF1R inhibitor in pre-clinical models of lung and colon cancers

Suchergebnisse filtern